Poster Abstract Session:
136. Healthcare Epidemiology: MDR-Gram Negative Infections
Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Pediatric ID, Global ID, Epidemiology and Infection Control, Adult ID


Presentations:
Epidemiology of Carbapenem-Resistant Pseudomonas aeruginosa Identified through the Emerging Infections Program (EIP), United States, 2016–2017
Julian Grass, MPH; Sandra Bulens, MPH; Wendy Bamberg, MD; Sarah J. Janelle, MPH, CIC; Patrick Stendel, MPH; Jesse T. Jacob, MD; Chris Bower, MPH; Stephen Sukumaran, MPH; Lucy E. Wilson, MD, ScM; Elisabeth Vaeth, MPH; Linda Li, MPH; Ruth Lynfield, MD, FIDSA; Paula Snippes Vagnone, MT (ASCP); Ginette Dobbins, BS; Erin C. Phipps, DVM, MPH; Emily B. Hancock, MS; Ghinwa Dumyati, MD, FSHEA; Rebecca Tsay, MPH, MLS; Rebecca Pierce, PhD, MS, BSN; P. Maureen Cassidy, MPH; Nicole West, MPH; Marion A. Kainer, MBBS, MPH; Daniel Muleta, MD, MPH; Jacquelyn Mounsey, BSN, RN, CCRP; Davina Campbell, MPH; Richard Stanton, PhD; Maria S. Karlsson, PhD; Maroya Spalding Walters, PhD, ScM
Impact of Difficult-to-treat Resistance on Survival in Gram-negative Bacteremia: A Risk-adjusted Analysis Using Electronic Health Record–based Clinical Data from 140 US Hospitals
Sameer S. Kadri, MD, MS; Yi Ling Lai, MPH; Emily E. Ricotta, ScM; Jeffrey Strich, MD; Ahmed Babiker, MBBS; Chanu Rhee, MD, MPH.; Michael Klompas, MD, MPH, FRCPC, FIDSA; John P. Dekker, M.D., Ph.D.; John H. Powers III, MD; Robert L. Danner, MD; Jennifer Adjemian, PhD
County-level Geographic Distribution of Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae across Outpatient Settings of the Veterans Health Administration, 2000-2017
Michihiko Goto, MD, MSCI; Rajeshwari Nair, PhD, MBBS, MPH; Daniel Livorsi, MD, MSc; Marin Schweizer, PhD; Michael Ohl, MD MSPH; Kelly Richardson, PhD; Brice Beck, MA; Bruce Alexander, PharmD; Eli Perencevich, MD, MS, FIDSA, FSHEA
Posters
  • ESCR Geography Poster.pdf (2.3 MB)
  • Development of a Bedside Tool to Predict the Probability of Drug-Resistant Pathogens among an Adult Population with Gram-Negative Infections
    Thomas P. Lodise Jr., PharmD, PhD; Nicole G. Bonine, PhD, MPH; J. Michael Ye, MS; Henry J. Folse, PhD; Patrick Gillard, PharmD, MS
    Trends in Multi-Drug Resistant Gonorrhea, Gonococcal Isolate Surveillance Project, United States, 1987-2016
    Sancta St. Cyr, MD, MPH; Ellen Kersh, PhD; Hillard Weinstock, MD, MPH; Elizabeth Torrone, PhD, MSPH
    Role of Extended-Spectrum Cephalosporin-Resistance in Recurrent Enterobacteriaceae Urinary Tract Infections
    Judith Anesi, MD; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA; Irving Nachamkin, DrPH, MPH, FIDSA; Charles Garrigan, MB; Warren Bilker, PhD; Jacqueline Omorogbe, BS; Lois Dankwa, BA; Mary K. Wheeler, MBE; Pam Tolomeo, MPH; Jennifer Han, MD, MSCE
    Posters
  • Anesi_IDweek_poster PDF.pdf (232.7 kB)
  • Impact on Mortality, Length of stay and Antibiotic Use in Allogenic and Autologous Stem Cell Transplant Patients Colonized with Carbapenemase-producing Enterobacteriaceae
    Rohma Ghani, MBBS; Siddharth Mookerjee, MPH; Benjamin Mullish, MBBS; Mark Thursz, MBBS; Julian Marchesi, PhD; Jiri Pavlu, MBBS; Frances Davies, MBBS
    Travel-associated multidrug-resistant organism acquisition and risk factors among US military personnel
    Gregory Buchek, MD; Katrin Mende, PhD; Kalyani Telu, MS; Susan J. Kaiser, BS; David R. Tribble, MD, DrPH; Jamie Fraser, MPH; Indrani Mitra, MS; Tahaniyat Lalani, MBBS, MHS; Heather Yun, MD, FIDSA
    A Cluster of Carbapenemase-Producing Acinetobacter baumannii
    Heather Young, MD; Caroline Croyle, MPH; Sarah J. Janelle, MPH, CIC; Bryan Knepper, MPH, MS, CIC; Jennifer Kurtz, BSN; Amber Miller, MSN, RN, CIC, CSPDT; Sara Reese, PhD, MPH, CIC, FAPIC; Kyle Schutz, MPH; Wendy Bamberg, MD
    Posters
  • CRAB poster PDF.pdf (375.9 kB)
  • Epidemiology of Carbapenem-Resistant Enterobacteriaceae, a 5-year Experience at a Tertiary Care Hospital
    Darunee Chotiprasitsakul, MD, MPH; Sirawat Srichatrapimuk, MD, PhD; Suppachok Kirdlarp, MD; Pitak Santanirand, PhD
    Risk Factors for ESBL Enterobacteriaceae Colonization Identified by Universal Admission Screening in a London Teaching Hospital
    Rahul Batra, MD; Jonathan Otter, PhD; Alex Natale, PhD; Olga Tosas, PhD; Eleonora Dyakova, Phd; Jonathan Edgeworth, PhD, MRCP, FRCPath
    Carbapenemase-producing Carbapenem-resistant Organism Colonization Screening Surveys — Maryland, April 2017–April 2018
    Richard B. Brooks, MD, MPH; Elisabeth Vaeth, MPH; Niketa M. Jani, PhD; Catherine E. Dominguez, PhD; Jonathan R. Johnston, MS
    A multicenter prospective study of clinical and molecular epidemiological analysis of carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing Enterobacteriaceae (CPE) in Japan
    Kayoko Hayakawa, MD, PhD; Hideaki Kato, MD; Ryota Hase, MD; Jumpei Hasumi, MD; Takahito Nei, MD; Ryuichi Nakano, PhD; Hisakazu Yano, MD; Maki Nagashima, M.T.; Norio Ohmagari, MD, MSc, PhD
    Incidence of Bacteremia and Bacteriuria with Antibiotic-resistant Enterobacteriaceae after Transrectal Ultrasound-Guided Biopsy of the Prostate (TRUSBP)
    Elie Saade, MD, MPH; Khalid M. Dousa, MD, FACP, CABIM; Brigid Wilson, PhD; Federico Perez, MD, MS; Curtis J. Donskey, MD
    Addition of Chronic Kidney Disease Status to Pitt Bacteremia Score Improves Prediction of Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Infections
    Heather Henderson, DVM; Eric Cober, MD; Sandra S. Richter, MD; Robert Salata, MD; Robert Kalayjian, MD; Richard Watkins, MD; Yohei Doi, MD, PhD; Keith Kaye, MD; Scott R. Evans, PhD; Vance G. Fowler Jr., MD; Robert Bonomo, MD; David Van Duin, MD, PhD
    Use of the Combination Antibiogram in the Era of MDR Gram Negative Pathogens
    Kenneth Klinker, PharmD; Kartikeya Cherabuddi, MD; Mark Redell, PharmD; Matthew Balogh, MBA; Jill Massey, PharmD, MBA; Michael Dudley, PharmD, FIDSA
    Risk factors for the acquisition of IMP-type carbapenemase-producing carbapenem-resistant Enterobacteriaceae in Japan: A matched case-control study
    Sho Saito, MD; Kayoko Hayakawa, MD, PhD; Masahiro Ishikane, MD, PhD; Taichi Tajima, RN; Nobuaki Matsunaga, MD, PhD, MPH; Satoshi Ide, MD; Noriko Kinoshita, MD; Yoshiki Kusama, MD; Yumiko Fujitomo, MD, PhD; Takato Nakamoto, MD; Yuta Toda, MD; Norio Ohmagari, MD, MSc, PhD
    Epidemological, clinical, and microbiological characteristics of Carbapenemase-producing Entereobacteriaceae bloodstream infection in Republic of Korea
    Jung Wan Park, MD; Se Yoon Park, MD; Hyungmin Lee, MD, PhD; Tae Hyong Kim, MD, PhD; Eun Jung Lee, MD; Eunyoung Lee, MD
    Resistance Patterns and Susceptibility Analysis of Klebsiella pneumoniae Infections in Service Members Who Sustained Trauma in Iraq and Afghanistan
    John Kiley, MD; Katrin Mende, PhD; Susan J. Kaiser, BS; Leigh Carson, MS; Dan Z. Lu, MS; Teresa Merritt, BS; Timothy Whitman, DO; Joseph L. Petfield, MD; David R. Tribble, MD, DrPH; Dana M. Blyth, MD
    Impact of Bloodstream Infections Caused by Multidrug Resistant Organisms on Performance Status: a KARS-Net Study
    Kyungmin Huh, MD, MSc; Doo Ryeon Chung, MD; Jae-Hoon Ko, MD; Young Eun Ha, MD; Si-Ho Kim, MD; Suhyun Oh, MD; Sukbin Jang, MD; Seokjun Mun, MD; Hee Jae Huh, MD; Nam Yong Lee, MD, PhD; Sun Young Cho, Dr.; Cheol-In Kang, MD; Kyong Ran Peck, MD; Jae-Hoon Song, MD, PhD
    Prevalence of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hospital Drains in Southern Ontario
    Alainna Jamal, Hons. BSc; Mahin Baqi, MD; Sergio Borgia, MD; William Cicotelli, MD; Kornelija Delibasic, ICP; Kevin Katz, MD, CM, MSc, FRCPC; Jennie Johnstone, MD, PhD; Roberto Melano, PhD; Matthew Muller, MD, FRCPC, PhD; Sharon O'Grady, ICP; Samir Patel, PhD; David Richardson, MD; Aimee Paterson, MSc; Angel Li, MSc; Allison McGeer, MD, MSc
    Posters
  • IDWeek Poster Alainna.pdf (372.6 kB)
  • Could Chlorehexidine (CHX) bathing decrease the incidence of Carbapenem-resistant Enterobacteria (CRE) bacteremia in previously Colonized CRE Hematopoietic Stem cell Transplant recipients (HSCT)?
    Juan Diego Velez, MD; Fernando Rosso, MD; Jorge Cedano, MD; Barbara Lucia Mora, MD; Marly Orrego, RN, MSC; Mayra Estacio, MD; Ivan Andres Beltran, RN
    Posters
  • POSTER 2 CRE AND HSCT.pdf (685.2 kB)
  • A comprehensive characterization of the emerging carbapenem-resistant Klebsiella pneumoniae clinical isolates from a public hospital in Lima - Peru
    Fiorella Krapp, MD, MS; Catherine Amaro, MD; Karen Ocampo, Biol; Lizeth Astocondor, MT; Noemi Hinostroza, Biol; Maribel Riveros, Biol; Coralith Garcia, PhD
    Reduction of Carbapenem-resistant Enterobacteria (CRE) infections and total Polymyxin B use due to a Comprehensive Infection Control strategy in Colombia.
    Juan Diego Velez, MD; Fernando Rosso, MD; Barbara Lucia Mora, MD; Jorge Cedano, MD; Marly Orrego, RN, MSC; Ivan Andres Beltran, RN; Jhon Jairo Echeverry, PharmD
    Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010-2015
    Thomas P. Lodise Jr., PharmD, PhD; Roger Echols, MD, FIDSA; Weiying Wang, MPH; Frank Corvino, PhD; Bin Cai, MD, PhD
    Identification of a Novel Enterobacter cloacae Isolate Producing an IMP-13 Metallo-Beta-Lactamase
    Muhammad Bilal Abid, MD, MRCP; Blake Buchan, PhD, D(ABMM); Nathan Ledeboer, PhD, D(ABMM); L. Silvia Munoz-Price, MD, PhD; Mary Beth Graham, MD, FIDSA
    Posters
  • ID week IMP poster-FINAL.pdf (337.4 kB)
  • Comparison of the clinical outcomes of patients with IMP-type carbapenemase-producing carbapenem-resistant Enterobacteriaceae and carbapenem-sensitive Enterobacteriaceae in Japan.
    Sho Saito, MD; Kayoko Hayakawa, MD, PhD; Masahiro Ishikane, MD, PhD; Taichi Tajima, RN; Nobuaki Matsunaga, MD, PhD, MPH; Satoshi Ide, MD; Noriko Kinoshita, MD; Yoshiki Kusama, MD; Yumiko Fujitomo, MD, PhD; Takato Nakamoto, MD; Yuta Toda, MD; Norio Ohmagari, MD, MSc, PhD
    Carbapenem-Resistant Enterobacteriaceae in Kentucky - Initial Six Months of Mechanism Testing
    Kevin Spicer, MD, PhD, MPH; Katelyn Cox, BS; Rachel Zinner, MS; Andrea Flinchum, MPH, BSN, CIC
    Posters
  • IDWeek_poster-1194_Spicer.pdf (555.6 kB)
  • Where You Live Matters: United States Region as a Significant Predictor of Mortality for ESBL Infection based on a descriptive study using NIS database
    Elizabeth George, MD, MPH; Sarah Aurit, Masters in Biostatistics; Christopher Destache, PharmD; Renuga Vivekanandan, MD
    Posters
  • 1195_IDWPOSTER.pdf (2.5 MB)
  • Serratia marcescens Strains Carrying blaKPC-2 and blaKPC-3 Carbapenemase Associated With Chronic Mechanical Ventilation
    Matthew Fisher, M.D.; Elizabeth Diago-Navarro, PhD; Olga Kaplun, MD; Eric Sin, MD; Bettina C. Fries, MD, FIDSA
    Microbiological Surveillance of Duodenoscopes Before and After High-Level Disinfection Following Endoscopic Retrograde Cholangiopancreatography (ERCP)
    Bert K. Lopansri, MD, FIDSA; Tasha Fernley, BS; Jana Coombs, BS; Michaela A. Gazdik, PhD; Lori Smit, RN, MS; Kristin K. Dascomb, MD, PhD; John Burke, MD, FIDSA, FSHEA
    Clinical Characteristics and Outcomes of Klebsiella pneumoniae Infections in Service Members Who Sustained Trauma in Iraq and Afghanistan
    John Kiley, MD; Katrin Mende, PhD; Susan J. Kaiser, BS; Leigh Carson, MS; Dan Z. Lu, MS; Timothy J. Whitman, DO; Joseph L. Petfield, MD; David R. Tribble, MD, DrPH; Dana M. Blyth, MD
    Epidemiology of Carbapenem Resistant Klebsiella pneumoniae: A comparative study between Facilities in the United States and the Dominican Republic
    Alfredo J. Mena Lora, MD; Rita Rojas Fermin, MD; Anel Guzman, MS; Scott Borgetti, MD; Susan C. Bleasdale, MD
    Posters
  • CRKp.pdf (925.3 kB)
  • Molecular Epidemiology of Cephalosporinases and Extended Spectrum Beta-lactamases (ESBLs) in Proteus mirabilis Isolates from Croatia: Following the Spread of Resistance Determinants between Long-term Care Facilities and the Community
    Tomislav Mestrovic, MD, PhD; Amarela Lukic-Grlic, MD, PhD; Maja Bogdan, MD; Daniela Bandic-Pavlovic, MD, PhD; Gordana Cavric, MD, PhD; Domagoj Drenjancevic, MD, PhD; Katherina Bernardette Sreter, MD; Ana Bencic, MD in training; Sanda Sardelic, MD, PhD; Branka Bedenic, MD, PhD
    A prolonged multispecies outbreak of carbapenemase-producing Enterobacteriaceae due to transmissible plasmid with carbapenemase gene.
    Takuya Yamagishi, MD, PhD; Mari Matsui, PhD; Tsuyoshi Sekizuka, PhD; Hiroaki Ito, MD; Munehisa Fukusumi, MD, PhD; Tomoko Uehira, MD, PhD; Miyuki Tsubokura, RN; Akio Tawa, MD, PhD; Shoji Nakamori, MD, PhD; Atsushi Miyamoto, MD, PhD; Hideki Yoshida, MD, PhD; Satowa Suzuki, MD, PhD; Keigo Shibayama, MD, PhD; Makoto Kuroda, PhD; Tamano Matsui, MD, PhD; Kazunori Oishi, MD, PhD
    Multimodal sequencing of a clonal case cluster of carbapenem-resistant Citrobacter reveals unexpectedly rapid dynamics of KPC3-containing plasmids
    Roby Bhattacharyya, MD PhD; Alejandro Pironti, PhD; Bruce J. Walker, PhD; Abigail Manson, PhD; Virginia Pierce, M.D.; Mary Jane Ferraro, PhD, FIDSA; Erica Shenoy, MD, PhD; David C. Hooper, MD; Ashlee Earl, PhD
    Molecular screening for Multi-drug Resistance Genes in Hospitalized Veterans
    Sarah Alsamarai, MD; Caitlin Biedron, MD; Barrett Holen, MD; Jesse Goodman, MD; Bona Yoon, MPH; Angelike P. Liappis, MD, FIDSA
    The MDR Upon Admission Score for Shortening Time to Initiation of Appropriate Antimicrobial Therapy in the Era of Widespread Resistance to Antimicrobials
    Khalil Chedid, MD, MPH; Shani Zilberman-Itskovich, MD; Akram Shorbaje, MD; Emily T. Martin, MPH, PhD; Tsilia Lazarovitch, PhD; Ronit Zaidenstein, M.D.; Mor Dadon, BsC; Hodaya Saadon, BS; Tal Maya, BS; Dror Marchaim, MD
    Emergence of Carbapenemase Producing Enterobacteriaceae in South Central Ontario, Canada
    Zoe Zhong, PhD; Amna Faheem, MBBS, MPH; Lubna Farooqi, MBBS; Irene Armstrong, MD; Emily Borgundvaag, MSc; Brenda Coleman, PhD; Karen Green, MSc, RN; Kithsiri Jayasinghe, MSc; Jennie Johnstone, MD, PhD; Kevin Katz, MD, CM, MSc, FRCPC; Philipp Kohler, MD; Angel Li, MSc; Roberto Melano, PhD; Matthew Muller, MD, FRCPC, PhD; Sarah Nayani, PhD; Samir Patel, PhD; Aimee Paterson, MSc; Susan Poutanen, MD, MPH; Anu Rebbapragada, PhD; David Richardson, MD; Alicia Sarabia, MD; Shumona Shafinaz, MD; Andrew E. Simor, MD, FRCPC, FACP; Barbara Willey, ART; Laura Wisely, RT; Allison Mcgeer, MD, MSc
    Risk Factors of Antibiotic Resistance in E. coli Isolated from the MAL-ED Birth Cohort Study in Rural Tanzania
    Molly Fleece, MD; Rosemary Nshama, BSc; Thomas Walongo, BSc; Jean Gratz, BSc; James Platts-Mills, MD; Esto Mduma, MPH; Eric Houpt, MD, FIDSA
    Posters
  • IDWeek2018poster.pdf (298.6 kB)
  • Acquisition and Quantification of Antimicrobial Resistance Genes in the Gut Microbiome of Ugandan Women Exposed to Small-scale Chicken Farming
    Meti D. Debela, BS; Daniel M. Muyanja, MBchB, MMed; Bernard Kakuhikire, MBA; Charles Baguma, MPH; David R. Bangsberg, MD, MPH; Alexander C. Tsai, MD, PhD; Ana A. Weil, MD, MPH; Peggy S. Lai, MD, MPH
    Posters
  • 1207_IDWPOSTER.pdf (419.4 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.